# IO Vancomycin in TSA

> **NCT05831774** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 33 (actual)

## Conditions studied

- Shoulder Injuries

## Interventions

- **DRUG:** Intervention - Intraosseous (IO) administration of vancomycin
- **DRUG:** Control - Standard IV administration of vancomycin

## Key facts

- **NCT ID:** NCT05831774
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2024-07-15
- **Final completion:** 2026-03-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05831774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05831774, "IO Vancomycin in TSA". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05831774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*